|
|
Volumn 173, Issue 6, 2005, Pages 1966-1968
|
|
Urologic oncology: Prostate cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
ANDROGEN RECEPTOR;
ANTIANDROGEN;
DIETHYLSTILBESTROL;
ESTROGEN;
ETHINYLESTRADIOL;
GONADORELIN AGONIST;
HERBACEOUS AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PC SPES;
PROSTATE SPECIFIC ANTIGEN;
WARFARIN;
ANTINEOPLASTIC AGENT;
HERBAL PREPARATION PC SPES;
HERBAL PREPARATION PC-SPES;
TUMOR MARKER;
CANCER HORMONE THERAPY;
CANCER SURVIVAL;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG TOLERABILITY;
FATIGUE;
FOLLOW UP;
GYNECOMASTIA;
HUMAN;
MALE;
MASTALGIA;
MEDICAL SOCIETY;
METASTASIS;
MONOTHERAPY;
NOTE;
ORCHIECTOMY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
PROSTATECTOMY;
THROMBOEMBOLISM;
TOXICITY;
TREATMENT OUTCOME;
ARTICLE;
BLOOD;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISEASE COURSE;
DRUG CONTAMINATION;
MULTICENTER STUDY;
NEOPLASM;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PHYSIOLOGY;
PHYTOTHERAPY;
PROSPECTIVE STUDY;
PROSTATE TUMOR;
RANDOMIZED CONTROLLED TRIAL;
ANDROGENS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CROSS-OVER STUDIES;
DIETHYLSTILBESTROL;
DISEASE PROGRESSION;
DRUG CONTAMINATION;
DRUGS, CHINESE HERBAL;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
NEOPLASMS, HORMONE-DEPENDENT;
PHYTOTHERAPY;
PROSPECTIVE STUDIES;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 18744378031
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1097/01.ju.0000161196.52248.3e Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|